1-3 of 3
Elizabeth Virtgaym
Close
Sort by
Journal Articles

Oral idasanutlin in patients with polycythemia vera

Clinical Trials & Observations
John Mascarenhas, Min Lu, Heidi Kosiorek, Elizabeth Virtgaym, Lijuan Xia, Lonette Sandy, Ruben Mesa, Bruce Petersen, Noushin Farnoud, Vesna Najfeld, Raajit Rampal, Amylou Dueck, Ronald Hoffman
Journal: Blood
Blood (2019) 134 (6): 525–533.
https://doi.org/10.1182/blood.2018893545
Published: 2019
Includes: Supplemental data
Journal Articles

Efficacy of Combined Ruxolitinib and Decitabine in Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms: Results of a Phase II Study (MPN-RC 109 trial)

Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Heidi E. Kosiorek, MS, Rupali Bhave, MD, Elizabeth O. Hexner, MD MS, Eunice S. Wang, MD, Aaron T. Gerds, MD MS, Mark L Heaney, MD PhD, Camille N Abboud, MD, Marina Kremyanskaya, MD PhD, Dmitriy Berenzon, MD, Olatoyosi Odenike, MD, Elizabeth Virtgaym, Lonette Sandy, Rona Singer Weinberg, PhD, Vesna Najfeld, PhD, Mohamed E. Salama, MD, Ross L. Levine, MD, Ruben A. Mesa, MD FACP, Amylou C. Dueck, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3027.
https://doi.org/10.1182/blood-2018-99-111935
Published: 2018
Journal Articles

Open Label Phase I Study of Single Agent Oral RG7388 (idasanutlin) in Patients with Polycythemia Vera and Essential Thrombocythemia

John Mascarenhas, MD, Min Lu, PhDMD, Elizabeth Virtgaym, Heidi Kosiorek, MS, Marina Stal, Lonette Sandy, Alicia Orellana, MD MPH, Lijuan Xia, Marina Kremyanskaya, MD PhD, Bruce Petersen, MD, Amylou Dueck, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 254.
https://doi.org/10.1182/blood.V130.Suppl_1.254.254
Published: 2017